EverHint Lens - Lemonade, Inc. (LMND) - Yahoo Finance Top Gainer (+16.7%) Stock Analysis - March 17, 2026
Analysis Date: 2026-03-17
Sector: Financial Services
Industry: Insurance - Property & Casualty
Exchange: NYSE
Executive Summary
Lemonade, Inc. is currently trading at $67.39 (🟢 +16.70% today) with a market capitalization of $5.15B.
Lemonade, Inc. provides various insurance products in the United States and Europe. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Price & Valuation
Current Price: $67.39 (at 12:30 PM ET)
Current Volume: 3.5M
Day Range: $62.00 - $67.42
52-Week Range: $24.31 - $99.90
P/E Ratio: -29.20
DCF Valuation: Not applicable (negative intrinsic value)
DCF model (unlevered) calculated as of 2026-03-17.
Market Context
Financial Services Sector: 0.06434% | Sector P/E: 24.91
Major Indices:
- S&P 500: $6722.96 (🟢 +0.35%)
- NASDAQ Composite: $22475.29 (🟢 +0.45%)
- Dow Jones Industrial Average: $47069.23 (🟢 +0.26%)
Peer Comparison
Peer comparison (11 companies):
- LMND - Lemonade, Inc. ($67.39, +16.7%, $5.15B) ← Current
- ALL - The Allstate Corporation ($207.46, -0.2%, $53.84B)
- RLI - RLI Corp. ($61.80, +0.5%, $5.68B)
- WTM - White Mountains Insurance Group, Ltd. ($2,234.57, +1.6%, $5.54B)
- FLG - Flagstar Financial, Inc. ($12.46, +0.1%, $5.18B)
- MCY - Mercury General Corporation ($91.26, +0.9%, $5.05B)
- SIGI - Selective Insurance Group, Inc. ($76.62, +0.1%, $4.63B)
- RDN - Radian Group Inc. ($33.09, +1.0%, $4.51B)
- LAZ - Lazard Ltd ($40.72, +1.6%, $3.86B)
- HGTY - Hagerty, Inc. ($10.70, +3.3%, $3.66B)
- AHL - ASPEN INSURANCE HOLDINGS LTD ($37.50, 0.0%, $3.44B)
Financial Performance
Latest Quarter (2025-12-31):
- Revenue: $228.10M
- Net Income: $-21.70M
- EPS: $-0.33
- Revenue Growth (QoQ): +17.3%
Earnings Calendar
Next Earnings Report: 2026-05-05 (Before Market Open)
- EPS Estimate: $-0.58
- Revenue Estimate: $0.25B
Most Recent Report: 2026-02-19
- EPS: $-0.29 (Est: $-0.39) ✓ Beat
- Revenue: $0.23B
Historical Data: 33 earnings events tracked
Analyst Outlook
Analyst Price Target Consensus:
- Target: $77.33 (+14.8% upside)
- Range: $44.00 - $98.00
- Median: $82.50
Next Quarter Estimates (2028-12-31):
- Revenue: $608.87M
- EPS: $0.41
Analyst Consensus
Overall Rating: Buy
Rating Distribution (130 total ratings):
- 🟢 Buy/Outperform: 43 (33.1%)
- ⚪ Hold/Neutral: 22 (16.9%)
- 🔴 Sell/Underperform: 34 (26.2%)
Recent Analyst Actions:
- Morgan Stanley (2026-03-17): Equal Weight → Overweight
- Keefe, Bruyette & Woods (2026-02-24): Maintained Underperform
- Cantor Fitzgerald (2026-01-14): Maintained Overweight
- Keefe, Bruyette & Woods (2025-11-25): Maintained Underperform
- Citizens (2025-11-24): Maintained Market Outperform
Consensus based on 130 analyst ratings from major financial institutions
Trading Signals
Our technical analysis identified 4 trading signal(s) in the last 60 days:
- 2026-02-18: Sma20 Sma50 - SMA20_x_SMA50_Sell @ $65.73
- 2026-02-05: Ema10 Ema30 - EMA10_x_EMA30_Sell @ $68.46
- 2026-01-22: Momentum Swing - breakout @ $96.57
- 2026-01-21: Ema10 Price Macd - EMA10_Price_MACD_Buy @ $85.36
Insider Activity
Recent Transactions (Last 10):
- Buys: 6
- Sells: 4
Notable Transactions:
- 2026-03-10: Angelidis-Smith Maria - Buy (Award, 5,390 shares @ $55.70)
- 2026-03-10: Angelidis-Smith Maria - Buy (Award, 3,350 shares @ $55.30)
- 2026-03-08: Eckstein Adina - Buy (Award, 145,112 shares)
Congressional Trading Activity
Tracking recent stock transactions by U.S. Congress members
House of Representatives: 7 transactions tracked
Recent Activity:
- 🟢 Marie Newman (IL03): Purchase on 2021-07-15, Amount: $15,001 - $50,000
- ⚪ Marie Newman (IL03): Sale (Full) on 2021-04-01, Amount: $1,001 - $15,000
- 🟢 Marie Newman (IL03): Purchase on 2021-03-01, Amount: $1,001 - $15,000
- 🟢 Marie Newman (IL03): Purchase on 2021-03-15, Amount: $1,001 - $15,000
- ⚪ Marie Newman (IL03): Sale (Full) on 2021-03-15, Amount: $1,001 - $15,000
U.S. Senate: 4 transactions tracked
Recent Activity:
- ⚪ Bill Hagerty: Sale (Partial) on 2022-05-06, Amount: $1,001 - $15,000
- ⚪ Bill Hagerty: Sale (Partial) on 2022-05-06, Amount: $1,001 - $15,000
- ⚪ Bill Hagerty: Sale (Partial) on 2021-01-08, Amount: $1,001 - $15,000
- ⚪ Bill Hagerty: Sale (Partial) on 2021-01-08, Amount: $1,001 - $15,000
Congressional trading data sourced from official disclosure filings
News Sentiment Analysis
AI Analysis (based on 30 recent articles):
Lemonade's Q4 earnings beat revenue expectations with 53% growth and narrower losses, alongside first positive cash flow, sparking bullish sentiment on AI-driven expansion and customer growth. However, stock volatility persisted with sharp February declines due to profitability concerns. Overall, media highlights buy opportunities and long-term potential despite risks.
Key Themes:
- Earnings Beats and Growth
- Stock Volatility
- AI Innovation and Future Upside
Sentiment: Positive (82% confidence)
Reddit Sentiment
Community Discussion (last 30 days from r/wallstreetbets, r/stocks, r/investing):
Overall Sentiment: Strongly Bullish 📈📈 (Score: 0.892)
Post Analysis:
- Total posts: 3
- Bullish: 3 (100.0%)
- Bearish: 0 (0.0%)
- Neutral: 0 (0.0%)
- Total engagement: 189 (upvotes + comments)
Note: Sentiment score ranges from -1.0 (very bearish) to +1.0 (very bullish), weighted by post engagement.
Recent News
5 most recent articles covering LMND:
- Why Shares of Lemonade Stock Tanked 40.3% Last Month (fool.com, 2026-03-08) — Read more
- Should You Buy Lemonade (LMND) While It's Below $65? (fool.com, 2026-03-07) — Read more
- Elo Mutual Pension Insurance Co Purchases Shares of 19,368 Lemonade, Inc. $LMND (defenseworld.net, 2026-03-06) — Read more
- Lemonade Stock Dropped by 36% in February. Here's What Happened. (fool.com, 2026-03-05) — Read more
- Lemonade: Reasons to Buy and Reasons to Sell (fool.com, 2026-03-04) — Read more
Full news analysis based on 30 recent articles
Generated by Everhint Lens - Quantitative Stock Analysis
Last updated: 2026-03-17 09:30:57 AM PDT
Disclaimer: This is not investment advice. Always do your own research before making investment decisions.